Related Experiment Video
Updated: Jun 5, 2025

Synthesis of Strong Adhesive Hydrogel, Gelatin O-Nitrosobenzaldehyde
Published on: November 11, 2022
An In Situ UV Cross-Linking Asymmetric Adhesive Hydrogel for Noncompressible Hemostasis and Postoperative Adhesion
Lingyuan Liu1, Feng Zhao2, Yiqun Zhang1
1Department of Polymer Science and Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China.
Abstract:
Noncompressible hemorrhage control is vital for clinical outcome after surgical treatment and prehospital trauma injuries. Meanwhile, wound bleeding and tissue damage could induce postoperative adhesions, leading to a severe threat to the health of patients. Considerable research had been conducted on the development of hemostatic and antiadhesive materials. However, it was still a great challenge to realize hemostasis and antiadhesion simultaneously especially in inaccessible and irregular wound sites. In this study, a kind of fluid hemostatic agent composed of gelatin methacryloyl/sulfobetaine methacrylate/oxidized konjac glucomannan (termed GOS) was developed, which spread immediately upon contacting the hepatic trauma surface and turned into hydrogels under UV radiation within 5 s, resulting in rapid hemostasis and firm adhesion to tissues (shear strength 486.08 kPa). Importantly, the surface of the as-formed GOS hydrogel exhibited lubricious and nonadhesive properties, exhibiting excellent anti-postoperative adhesion performance in a rat liver hemostasis model and a rat abdominal wall-cecum adhesion model. In addition, the GOS hydrogel reduced the postoperative secretion of inflammatory factors TNF-α and IL-6, facilitating the tissue repair. Therefore, the asymmetrical adhesive GOS hydrogel could fulfill the requirements for simultaneously rapid hemostasis, tissue adhesion, and subsequent excellent antiadhesion, which demonstrated significant potential for diverse clinical surgical operation scenarios.
More Related Videos
Related Concept Videos
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins

